(Q34468189)

2 August 2017

1 reference

title

Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years (English)

1 reference

2 August 2017

1 reference

3

Georges Vlastos

1 reference

2 August 2017

4

S Eva Singletary

1 reference

2 August 2017

Attiqa N Mirza

1

1 reference

2 August 2017

Nadeem Q Mirza

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

2 August 2017

1 reference

2 August 2017

235

1 reference

2 August 2017

1

1 reference

2 August 2017

10-26

1 reference

The prognostic value of c-erbB2 in primary breast carcinomas: a study on 942 cases

2 August 2017

1 reference

12 December 2020

Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases

1 reference

12 December 2020

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

1 reference

12 December 2020

Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia

1 reference

12 December 2020

Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer

1 reference

12 December 2020

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

12 December 2020

Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications

1 reference

12 December 2020

Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study.

1 reference

12 December 2020

Prognosis of a series of 763 consecutive node-negative invasive breast cancer patients without adjuvant therapy: analysis of clinicopathological prognostic factor

1 reference

12 December 2020

The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer

1 reference

12 December 2020

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

1 reference

12 December 2020

c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study

1 reference

12 December 2020

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

1 reference

12 December 2020

The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years

1 reference

12 December 2020

P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up

1 reference

12 December 2020

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

1 reference

12 December 2020

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

12 December 2020

A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma

1 reference

12 December 2020

Prognostic factors for patients with breast cancers 1cm and smaller

1 reference

12 December 2020

S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer

1 reference

12 December 2020

Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay

1 reference

12 December 2020

Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables.

1 reference

12 December 2020

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

1 reference

12 December 2020

Estrogen receptor status as a prognostic indicator for stage I breast cancer patients

1 reference

12 December 2020

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

12 December 2020

Cathepsin D and prognosis in breast cancer

1 reference

12 December 2020

Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast

1 reference

12 December 2020

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

1 reference

12 December 2020

The long term prognostic significance of c-erbB-2 in primary breast cancer

1 reference

12 December 2020

Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor

1 reference

12 December 2020

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

1 reference

12 December 2020

Prognostic value of total cathepsin D in breast tumors. A possible role in selection of chemoresistant patients

1 reference

12 December 2020

Mitotic indexes as prognostic predictors in female breast cancer

1 reference

12 December 2020

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

12 December 2020

Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group

1 reference

12 December 2020

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

12 December 2020

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

12 December 2020

Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer

1 reference

12 December 2020

Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis

1 reference

12 December 2020

The prognostic value of lymphatic and blood vessel invasion in operable breast cancer

1 reference

12 December 2020

Tumor markers for breast cancer. Current utilities and future prospects

1 reference

12 December 2020

Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers

1 reference

12 December 2020

Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.

1 reference

12 December 2020

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

1 reference

12 December 2020

HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications

1 reference

12 December 2020

Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer

1 reference

12 December 2020

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

12 December 2020

Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis.

1 reference

12 December 2020

The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer

1 reference

12 December 2020

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

1 reference

12 December 2020

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers

1 reference

12 December 2020

1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology

1 reference

12 December 2020

Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?

1 reference

12 December 2020

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study

1 reference

12 December 2020

Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients

1 reference

12 December 2020

Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.

1 reference

12 December 2020

Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort.

1 reference

12 December 2020

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

12 December 2020

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

12 December 2020

Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer

1 reference

12 December 2020

Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival

1 reference

12 December 2020

Roles of the matrix metalloproteinases in mammary gland development and cancer

1 reference

12 December 2020

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

1 reference

12 December 2020

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

1 reference

12 December 2020

Survival After Breast Cancer in Ashkenazi Jewish BRCA1 and BRCA2 Mutation Carriers

1 reference

12 December 2020

Prognostic and predictive value of p53 and p21 in breast cancer

1 reference

12 December 2020

The relationship between prognostic and predictive factors in the management of breast cancer

1 reference

12 December 2020

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

12 December 2020

Prognostic significance of c-erbB-2 expression in node negative breast cancer

1 reference

12 December 2020

Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study

1 reference

12 December 2020

Prognostic factors and therapeutic decisions in axillary node-negative breast cancer

1 reference

12 December 2020

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

12 December 2020

S-phase fraction is a prognostic factor in stage I breast carcinoma

1 reference

12 December 2020

Prognostic significance of p53 gene alterations in node-negative breast cancer

1 reference

12 December 2020

Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer

1 reference

12 December 2020

Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer

1 reference

12 December 2020

DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients

1 reference

12 December 2020

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

1 reference

12 December 2020

Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up

1 reference

12 December 2020

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

12 December 2020

Prognostic factors in early breast carcinoma.

1 reference

12 December 2020

S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer

1 reference

12 December 2020

Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis.

1 reference

12 December 2020

An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis

1 reference

12 December 2020

10.1097/00000658-200201000-00003

Identifiers

DOI

1 reference

release_w4mv47wrabd2jgquaqtjgcgy3e

2 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w4mv47wrabd2jgquaqtjgcgy3e

24 November 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/w4mv47wrabd2jgquaqtjgcgy3e

24 November 2022

mapped directly with Wikidata item

1 reference